Report Detail

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global SPECT Radiopharmaceuticals market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of SPECT Radiopharmaceuticals Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in SPECT Radiopharmaceuticals Market?
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer Healthcare (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
...
Major Type of SPECT Radiopharmaceuticals Covered in XYZResearch report:
Tc-99
Tl-201
Ga-67
I-123
Others
Application Segments Covered in XYZResearch Market
Diagnostics
Therapeutics

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global SPECT Radiopharmaceuticals Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Tc-99 -Product Introduction and Major Manufacturers
        • 1.1.2 Tl-201 -Product Introduction and Major Manufacturers
        • 1.1.3 Ga-67 -Product Introduction and Major Manufacturers
        • 1.1.4 I-123 -Product Introduction and Major Manufacturers
        • 1.1.5 Others -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Regional Market Analysis

      • 2.1 China SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.1.1 China SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.1.2 China SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.2 EU SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.2.1 EU SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.2.2 EU SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.3 USA SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.3.1 USA SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.3.2 USA SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.4 Japan SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.4.1 Japan SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.4.2 Japan SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.5 India SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.5.1 India SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.5.2 India SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.6 Southeast Asia SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.6.1 Southeast Asia SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.6.2 Southeast Asia SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.7 South America SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.7.1 South America SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.7.2 South America SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.8 SPECT Radiopharmaceuticals Status and Prospect (2016-2027)
        • 2.8.1 SPECT Radiopharmaceuticals Market Size and Growth Rate (2016-2027)
        • 2.8.2 SPECT Radiopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

      3 Global SPECT Radiopharmaceuticals Market Assessment by Segment

      • 3.1 Global SPECT Radiopharmaceuticals Capacity and Growth Rate
      • 3.2 Global SPECT Radiopharmaceuticals Sales by Type
      • 3.3 Global SPECT Radiopharmaceuticals Sales Revenue by Type
      • 3.4 Global SPECT Radiopharmaceuticals Consumption by Application

      4 Global SPECT Radiopharmaceuticals Market Assessment by Regions

      • 4.1 Global SPECT Radiopharmaceuticals Production Analysis and Forecast by Regions (2016-2027)
      • 4.2 Global SPECT Radiopharmaceuticals Sales Analysis and Forecast by Regions (2016-2027)
      • 4.3 Global SPECT Radiopharmaceuticals Sales Revenue Analysis and Forecast by Regions (2016-2027)

      5 Value Chain (Impact of COVID-19)

      • 5.1 SPECT Radiopharmaceuticals Value Chain Analysis
        • 5.1.1 Upstream
        • 5.1.2 Downstream
      • 5.2 COVID-19 Impact on SPECT Radiopharmaceuticals Industry
        • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 5.3 Cost-Under the Epidemic Situation
        • 5.3.1 Cost of Raw Material
      • 5.4 Channel Analysis
        • 5.4.1 Distribution Channel-Under the Epidemic Situation
        • 5.4.2 Distributors

      6 Competitive Landscape

      • 6.1 Global SPECT Radiopharmaceuticals Capacity Market Share of Manufacturers (2019-2020)
      • 6.2 Global SPECT Radiopharmaceuticals Sales Market Share of Manufacturers (2019-2020)
      • 6.3 Global SPECT Radiopharmaceuticals Sales Revenue Market Share of Manufacturers (2019-2020)

      7 SPECT Radiopharmaceuticals Competitive Analysis

      • 7.1 Cardinal Health Inc. (U.S.)
        • 7.1.1 Cardinal Health Inc. (U.S.) Company Profiles
        • 7.1.2 Cardinal Health Inc. (U.S.) Product Introduction
        • 7.1.3 Cardinal Health Inc. (U.S.) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.1.4 SWOT Analysis
      • 7.2 Mallinckrodt plc (Ireland)
        • 7.2.1 Mallinckrodt plc (Ireland) Company Profiles
        • 7.2.2 Mallinckrodt plc (Ireland) Product Introduction
        • 7.2.3 Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.2.4 SWOT Analysis
      • 7.3 GE Healthcare (U.K.)
        • 7.3.1 GE Healthcare (U.K.) Company Profiles
        • 7.3.2 GE Healthcare (U.K.) Product Introduction
        • 7.3.3 GE Healthcare (U.K.) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.3.4 SWOT Analysis
      • 7.4 Lantheus Medical Imaging, Inc. (U.S.)
        • 7.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profiles
        • 7.4.2 Lantheus Medical Imaging, Inc. (U.S.) Product Introduction
        • 7.4.3 Lantheus Medical Imaging, Inc. (U.S.) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.4.4 SWOT Analysis
      • 7.5 Bayer Healthcare (Germany)
        • 7.5.1 Bayer Healthcare (Germany) Company Profiles
        • 7.5.2 Bayer Healthcare (Germany) Product Introduction
        • 7.5.3 Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.5.4 SWOT Analysis
      • 7.6 Bracco Imaging S.p.A (Italy)
        • 7.6.1 Bracco Imaging S.p.A (Italy) Company Profiles
        • 7.6.2 Bracco Imaging S.p.A (Italy) Product Introduction
        • 7.6.3 Bracco Imaging S.p.A (Italy) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.6.4 SWOT Analysis
      • 7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
        • 7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profiles
        • 7.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Product Introduction
        • 7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.7.4 SWOT Analysis
      • 7.8 Nordion, Inc. (Canada)
        • 7.8.1 Nordion, Inc. (Canada) Company Profiles
        • 7.8.2 Nordion, Inc. (Canada) Product Introduction
        • 7.8.3 Nordion, Inc. (Canada) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.8.4 SWOT Analysis
      • 7.9 Advanced Accelerator Applications S.A. (France)
        • 7.9.1 Advanced Accelerator Applications S.A. (France) Company Profiles
        • 7.9.2 Advanced Accelerator Applications S.A. (France) Product Introduction
        • 7.9.3 Advanced Accelerator Applications S.A. (France) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.9.4 SWOT Analysis
      • 7.10 IBA Molecular Imaging (Belgium)
        • 7.10.1 IBA Molecular Imaging (Belgium) Company Profiles
        • 7.10.2 IBA Molecular Imaging (Belgium) Product Introduction
        • 7.10.3 IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Production, Revenue (2015-2020)
        • 7.10.4 SWOT Analysis

      8 Conclusion

      Summary:
      Get latest Market Research Reports on SPECT Radiopharmaceuticals. Industry analysis & Market Report on SPECT Radiopharmaceuticals is a syndicated market report, published as Post-pandemic Era-Global SPECT Radiopharmaceuticals Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin. It is complete Research Study and Industry Analysis of SPECT Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,620.00
      $5,500.00
      2,885.14
      4,383.50
      3,362.98
      5,109.50
      554,692.60
      842,765.00
      302,052.80
      458,920.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report